Global Diabetes Devices Market Research Report 2021 - Impact of COVID-19 on the Market

SKU ID :Maia-18896989 | Published Date: 12-Aug-2021 | No. of pages: 118
Diabetes is a disease that occurs when your blood glucose, also called blood sugar, is too high. Blood glucose is your main source of energy and comes from the food you eat. Insulin, a hormone made by the pancreas, helps glucose from food get into your cells to be used for energy. Sometimes your body doesn’t make enough—or any—insulin or doesn’t use insulin well. Glucose then stays in your blood and doesn’t reach your cells. The existence of devices like testing strips, continuous monitoring devices, lancets, self-monitoring blood glucose metres.
The Diabetes Devices market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.

Considering the influence of COVID-19 on the global Diabetes Devices market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Diabetes Devices Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Diabetes Devices market are:
Becton
Cellnovo
Medtronic
Owen Mumford Ltd.
Insulet Corporation
Eli Lilly and Company
Novo Nordisk A/S
Tandem Diabetes Care, Inc.
F. Hoffmann-La Roche Ltd.
Sanofi
Abbott Laboratories
LifeScan, Inc.
Dickinson and Company

Most important types of Diabetes Devices products covered in this report are:
Glucose Monitoring Devices
Insulin Delivery Devices
Diabetes Management Software
Artificial Pancreas System

Most widely used downstream fields of Diabetes Devices market covered in this report are:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Diabetes Clinics/ Centres

Major Region

s or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.

Years considered for this report:


Historical Years:

2016-2020

Base Year:

2020

Estimated Year:

2021

Forecast Period:

2021-2026
  • PRICE
  • $3000
    $6000
    $4250
    Buy Now

Our Clients